VAXARRAY®
Designed To Reduce Your Analytical Development Bottlenecks.
With fast evolving diseases and pandemics, the challenge of analytical development for the vaccine industry has never been so great. The need to provide patients with effective and safe vaccines in reduced time frames is increasing. Your vaccine candidates’ development require optimization by reducing your analytical bottlenecks.
With a partner-first approach to the pharmaceutical industry, bioMérieux joins forces with U.S. biotechnology Company InDevR, manufacturer of the VaxArray® technology, to provide the vaccine industry with a new simplified and rapid analytical solution.
VaxArray® is a multiplexed immunoassay technology for vaccine characterization. It allows manufacturers to have clearer insights into the evolution, manufacturing and release of their vaccine products.
- Image 1
- Image 2
- Image 2
- Product Overview
- Technology
- Reagents
- Support and Services
- Resources
Product Overview
VaxArray® is a multiplexed immunoassay technology for protein and mRNA-based vaccines potency and characterization. It allows manufacturers to have clearer insights into the evolution, manufacture and release of their vaccine products.
VaxArray® offers off-shelf kits for Influenza and Pneumococcal applications.
Working on other applications? Contact us and meet with our expert services. We can develop customs kits, specifically tailored for your vaccine. We also provide testing services for fast and effective answers.
bioMérieux is the exclusive distributor of VaxArray® in Europe.
Technology
The VaxArray® technology relies on multiplexed immunoassays with fluorescent detection labels. VaxArray® is compatible with different therapeutic modalities including egg- and cell-based vaccine production methods as well as mRNA in vivo expression.
Benefits
- Increased analytical development efficiency
- Analytical development cost optimization
Features
- Early available ready-to-use kits for every flu campaign
- Fast time to result
- Easier to use than in-house methods
- Low volume sample required for testing
- Highly multiplexed for broad valence capture
- Compatible from crude to purified samples
- High sensitivity
- Software is 21 CFR Part 11 compatible
Reagents
A variety of off-shelf kits is available for influenza and pneumococcal applications.
For other applications, refer to our Expert Services.
Please note that the detection labels are to be purchased separately from the kits.
The multiplexing ability of VaxArray® relies on the precise geographical printing of the capture molecule onto the slide.
Influenza multivalent kits
- OmniFlu HA Multivalent Assay
- Influenza HEK293 HA Multivalent
- VaxArray® Influenza Seasonal HA Multivalent Assay V3.0 and V4.0
- Influenz Pandemic HA Multivalent Assay V1.1
- VaxArray® Influenza Seasonal NA Multivalent Assay V2.0
- VaxArray® Influenza NP Multivalent Assay
Influenza monovalent kits
- Influenza A/H1 Assay
- Influenza A/H3 Assay V2.0
- Influenza A/H3 Assay V3.0
- Influenza B/Yamagata HA Assay
- Influenza B/Victoria HA Assay
Pneumococcal multivalent kit
- Pneumococcal multivalent assay
Support and Services
- Testing services
- Custom services
- On-demand scientific support
- Installation, operation and performance qualification support
Resources - Brochures
InDevR - OmniFlu HA (Brochure)
Download the Brochure
- Filename
- InDevR_Flyer_2-OmniFlu_HA-DIGITAL.pdf
- Size
- 348 KB
- Format
- application/pdf
InDevR - Expert Services (Brochure)
Download the Document
- Filename
- InDevR_Flyer_3-Expert_Services-DIGITAL.pdf
- Size
- 419 KB
- Format
- application/pdf
InDevR - mRNA Applications (Brochure)
Download the Document
- Filename
- InDevR_Flyer_4-mRNA-draft6.pdf
- Size
- 525 KB
- Format
- application/pdf
InDevR - VaxArray (Brochure)
Download the Document
- Filename
- InDevR_Flyer_5-VaxArray-DIGITAL.pdf
- Size
- 466 KB
- Format
- application/pdf
Webinar
Next Generation MRNA CQA Analytics
Whitepapers
VaxArray for Rapid CQA Identity and Quantity for Multivalent mRNA Drug Product
Download the Document
- Filename
- 2022 VaxArray for Rapid CQA Identity and Quantity for Multivalent mRNA Drug Product (1).pdf
- Size
- 16 MB
- Format
- application/pdf
VaxArray 30-Minute Multiplexed Assay for Pneumococcal Vaccine Antigen Characterization
Download the Document
- Filename
- 2022 VaxArray 30-Minute Multiplexed Assay for Pneumococcal Vaccine Antigen Characterization.pdf
- Size
- 2 MB
- Format
- application/pdf
2019 VaxArray Why Quantitative Assessment of NA is as Critical as HA
Download the Document
- Filename
- 2019 VaxArray Why Quantitative Assessment of NA is as Critical as HA.pdf
- Size
- 1017 KB
- Format
- application/pdf
VaxArray Pandemic Influenza Potency Test Assessment and Comparison to SRID
Download the Document
- Filename
- 2018 VaxArray Pandemic Influenza Potency Test Assessment and Comparison to SRID.pdf
- Size
- 2 MB
- Format
- application/pdf
2018 FDA and InDevR VaxArray HA and NA Quantitation Compared with SRID
Download the Document
- Filename
- 2018 FDA and InDevR VaxArray HA and NA Quantitation Compared with SRID.pdf
- Size
- 1 MB
- Format
- application/pdf
GSK and InDevR VaxArray Replacing SRID with Improved Analytical Testing
Download the Document
- Filename
- 2017 GSK and InDevR VaxArray Replacing SRID with Improved Analytical Testing.pdf
- Size
- 1 MB
- Format
- application/pdf
Go Further
- The Hunt for the Missing Endotoxin
- The Hunt for the Missing Endotoxin